Figure 1.

Workflow of the suspect screening analysis including the feature MS/MS identification and confirmation steps for the 30 pairs of pregnant women and umbilical cord serum. (*Tiers 1–3 also each include the 100% detection frequency criteria as mentioned in the methods section.)